The effects of escalating doses of smoked cocaine in humans

Drug and Alcohol Dependence

Volumn 70, Issue 2, 2003, Pages 149-157

  Foltin, Richard W ^a   Ward, Amie S ^a   Haney, Margaret ^a   Hart, Carl L ^a   Collins, Eric D ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cardiovascular effects; Cocaine; Dose response; Humans; Self administration; Subjective effects

Indexed keywords

COCAINE;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DOSE RESPONSE; DRUG SELF ADMINISTRATION; HEART RATE; HUMAN; MALE; MOOD; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AFFECT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HUMANS; MALE; SELF ADMINISTRATION;

EID: 0042921425     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00343-5     Document Type: Article

References (27)

1. Bigelow G.E., Walsh S.L. Evaluation of potential pharmacotherapies: response to cocaine challenge in the human laboratory. Higgins S.T., Katz J.L. Cocaine Abuse: Behavior, Pharmacology, and Clinical Applications. 1998;209-237 Academic Press, New York.
2. Brower K.J., Hierholzer R., Maddahian E. Recent trends in cocaine abuse in a VA psychiatric population. Hosp. Community Psychiatr. 37:1986;1229-1234.
3. Deroche V., Le Moal M., Piazza P.V. Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur. J. Neurosci. 11:1999;2731-2736.
4. Emmett-Oglesby M.W., Shippenberg T.S., Herz A. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine. J. Pharmacol. Exp. Ther. 245:1988;7-23.
5. Evans S.M., Haney M., Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berlin). 159:2002;397-406.
6. Foltin R.W., Fischman M.W. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J. Pharmacol. Exp. Ther. 261:1992;623-632.
7. Foltin R.W., Haney M. Conditioned effects of environmental stimuli paired with smoked cocaine in humans. Psychopharmacology (Berlin). 149:2000;24-33.
8. Foltin R.W., Fischman M.W., Nestadt G., Stromberger H., Cornell E.E., Pearlson G.D. Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend. 26:1990;145-154.
9. Foltin R.W., Fischman M.W., Cornell E.L., Butler L. Characteristics of a non-treatment sample of heavy cocaine users volunteering for studies involving cocaine administration in Baltimore (USA). Addict. Res. 4:1996;139-149.
10. France C.P., Woods J.H. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure. J. Pharmacol. Exp. Ther. 234:1985;81-89.
11. Gawin F.H., Kleber H.D. Neuroendocrine findings in chronic cocaine abusers: a preliminary report. Br. J. Psychiatr. 147:1985;569-573.
12. Haney M., Ward A.S., Foltin R.W., Fischman M.W. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berlin). 155:2001;330-337.
13. Hatsukami D.K., Pentel P.R., Glass J., Nelson R., Brauer L.H., Crosby R., Hanson K. Methodological issues in the administration of multiple doses of smoked cocaine-base in humans. Pharmacol. Biochem. Behav. 47:1994;531-540.
14. Hiltunen A.J., Järbe T.U.C. Discriminative stimulus properties of ethanol: effects of cumulative dosing and RO 15-4513. Behav. Pharmacol. 1:1989;133-140.
15. Hiltunen A.J., Järbe T.U.C. Acute tolerance to ethanol using drug discrimination and open-field procedures in rats. Psychopharmacology (Berlin). 102:1990;207-212.
16. Nann-Vernotica E., Donny E.C., Bigelow G.E., Walsh S.L. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology (Berlin). 155:2001;338-347.
17. Oliveto A., McCance-Katz F.E., Singha A., Petrakis I., Hameedi F., Kosten T.R. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug Alcohol Depend. 63:2001;155-167.
18. Rush C.R., Baker R.W., Wright K. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis. Drug Alcohol Depend. 55:1999;1-12.
19. Schechter M.D. Discrete versus cumulative dosing in dose-response discrimination studies. Eur. J. Clin. Nutr. 326:1997;113-118.
20. Segal D.S., Kuczenski R. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav. Brain Res. 88:1997;251-260.
21. Segal D.S., Kuczenski R. An escalating dose 'binge' model of amphetamine psychosis: behavioral and neurochemical characteristics. J. Neurosci. 17:1997;2551-2556.
22. Segal D.S., Kuczenski R. Repeated binge exposure to amphetamine and methamphetamine: behavioral and neurochemical characterization. J. Pharmacol. Exp. Ther. 282:1997;561-573.
23. Trinkoff A.M., Ritter C., Anthony J.C. The prevalence and self-reported consequences of cocaine use: an exploratory and descriptive analysis. Drug Alcohol Depend. 26:1990;217-225.
24. Walsh S.L., Sullivan J.T., Preston K.L., Garner J.E., Bigelow G.E. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J. Pharmacol. Exp. Ther. 279:1996;524-538.
25. Walsh S.L., Haberny K.A., Bigelow G.E. Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology (Berlin). 150:2000;361-373.
26. Ward A.S., Haney M., Fischman M.W., Foltin R.W. Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berlin). 132:1997;375-381.
27. Ward A.S., Haney M., Fischman M.W., Foltin R.W. Binge cocaine self-administration by humans: smoked cocaine. Behav. Pharmacol. 8:1997;736-744.